CTI BioPharma Corp

Home » CTI BioPharma Corp

IPO

CTI BioPharma Corp

They are a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies covering a spectrum of blood-related cancers that offer a unique benefit to patients and healthcare providers.

Symbol

CTIC

Price Range
$2.82 - $3.01

Anticipated Shares
17,500,000

Effective Date
February 9, 2018

Underwriters
Leerink Partners

To view the prospectus for CTI BioPharma Corp IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253